Artiva Investigational Site Birmingham

Birmingham, Alabama 35249

0 studies enrolling now · 1 studies all time

What they study most

Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV, Refractory Systemic Lupus Erythematosus, SLE

Studies at this site

• AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus — Running, not enrolling